INTERIM CONSOLIDATED BALANCE SHEETS (UNAUDITED) (USD $)	Apr. 30, 2014	Jul. 31, 2013	Apr. 30, 2014 Series A Convertible Preferred Stock	Jul. 31, 2013 Series A Convertible Preferred Stock	Apr. 30, 2014 Series B Convertible Preferred Stock	Jul. 31, 2013 Series B Convertible Preferred Stock	Apr. 30, 2014 Series C Convertible Preferred Stock	Jul. 31, 2013 Series C Convertible Preferred Stock	Apr. 30, 2014 Series D Convertible Preferred Stock	Jul. 31, 2013 Series D Convertible Preferred Stock	Jun. 17, 2014 Series E Convertible Preferred Stock	Jul. 31, 2013 Series E Convertible Preferred Stock	Apr. 30, 2014 Series F Convertible Preferred Stock	Jul. 31, 2013 Series F Convertible Preferred Stock
ASSETS
Cash and cash equivalents	$ 4,218,735	$ 1,708,954
Other current assets	45,506	98,315
Total Current Assets	4,264,241	1,807,269
Property and Equipment, Net	14,049	85,406
Assets Held for Investment, Net (Note 11)		640,772
Patents, Net	2,105,448	2,319,416
TOTAL ASSETS	6,383,738	4,852,863
LIABILITIES AND STOCKHOLDERS' (DEFICIENCY)/EQUITY
Accounts payable and accrued expenses (Note 5)	8,105,356	7,661,234
Deferred revenue	223,662	224,843
Current maturities of long-term debt (Note 11)		617,665
Total Current Liabilities	8,329,018	8,503,742
Derivative Warrant Liability (Note 10)	5,699,770	5,234,293
Derivative Additional Investment Rights Liability (Note 10)	819,882	1,256,160
Total Liabilities	14,848,670	14,994,195
Stockholders' Deficiency (Note 9):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 1,500,000,000 shares at April 30, 2014 and July 31, 2013; 750,103,804 and 580,329,160 issued and outstanding at April 30, 2014 and July 31, 2013, respectively	750,103	580,329
Additional paid-in capital	362,112,407	356,401,812
Deficit accumulated during the development stage	(372,102,178)	(367,888,576)
Accumulated other comprehensive income	774,736	765,103
Total Stockholders' Deficiency	(8,464,932)	(10,141,332)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$ 6,383,738	$ 4,852,863